Changes in Self-Schema Structure in Cognitive Therapy for Major Depressive Disorder: A Randomized Clinical Trial

Autor/inn/en	Dozois, David J. A.; Bieling, Peter J.; Patelis-Siotis, Irene; Hoar, Lori; Chudzik, Susan; McCabe, Katie; Westra, Henny A.
Titel	Changes in Self-Schema Structure in Cognitive Therapy for Major Depressive Disorder: A Randomized Clinical Trial
Quelle	In: Journal of Consulting and Clinical Psychology, 77 (2009) 6, S.1078-1088 (11 Seiten) PDF als Volltext Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	0022-006X
DOI	10.1037/a0016886
Schlagwörter	Cognitive Structures; Cognitive Restructuring; Rating Scales; Patients; Therapy; Depression (Psychology); Behavior Modification; Schemata (Cognition); Self Concept; Drug Therapy; Measures (Individuals); Hamilton Rating Scale for Depression; Beck Depression Inventory + Suchen Sie Ihr Suchwort? Cognitive structure; Kognitive Struktur; Rating-Skala; Patient; Therapie; Behaviour modification; Verhaltensänderung; Cognition; Schema; Kognition; Selbstkonzept; Messdaten
Abstract	Negative cognitive structure (particularly for interpersonal content) has been shown in some research to persist past a current episode of depression and potentially to be a stable marker of vulnerability for depression (D. J. A. Dozois, 2007; D. J. A. Dozois & K. S. Dobson, 2001a). Given that cognitive therapy (CT) is highly effective for treating the acute phase of a depressive episode and that this treatment also reduces the risk of relapse and recurrence, it is possible that CT may alter these stable cognitive structures. In the current study, patients were randomly assigned to CT+ pharmacotherapy (n = 21) or to pharmacotherapy alone (n = 21). Both groups evidenced significant and similar reductions in level of depression (as measured with the Beck Depression Inventory-II and the Hamilton Rating Scale for Depression), as well as automatic thoughts and dysfunctional attitudes. However, group differences were found on cognitive organization in favor of individuals who received the combination of CT+ pharmacotherapy. The implications of these results for understanding mechanisms of change in therapy and the prophylactic nature of CT are discussed. (Contains 3 figures and 4 tables.) (As Provided).
Anmerkungen	American Psychological Association. Journals Department, 750 First Street NE, Washington, DC 20002-4242. Tel: 800-374-2721; Tel: 202-336-5510; Fax: 202-336-5502; e-mail: order@apa.org; Web site: http://www.apa.org/publications
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2017/4/10